Hengkang Medical Group Co.Ltd(002219)
Securities abbreviation: Hengkang Medical Group Co.Ltd(002219) securities code: 002219 Announcement No.: 2022-014
Hengkang Medical Group Co.Ltd(002219) administrator
Announcement on abnormal fluctuation of stock trading
The manager of the company, the company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and there are no false records, misleading statements or major omissions.
1、 Description of abnormal fluctuations in stock trading
Hengkang Medical Group Co.Ltd(002219) (hereinafter referred to as the “company”) (Securities abbreviation: Hengkang Medical Group Co.Ltd(002219) , securities code: 002219) the stock trading price has deviated from the closing price for three consecutive trading days (January 28, 2022, February 7, 2022 and February 8, 2022) by more than 12%. According to the relevant provisions of the trading rules of Shenzhen Stock Exchange, it is an abnormal fluctuation of stock trading.
2、 Description of the situation concerned and verified by the manager
In view of the abnormal fluctuation of the company’s stock trading, the Manager checked the relevant matters, and the relevant information is described as follows:
1. The company has not found any unpublished material information that may or has had a great impact on the company’s stock trading price reported by the public media recently.
2. The disclosed business conditions and internal and external business environment of the company have not changed significantly, and the production and operation activities of the company are normal.
3. The information disclosed by the company in the early stage does not need to be corrected or supplemented.
4. The company and the controlling shareholders do not have any major events that should be disclosed but not disclosed about the company, nor do they have any major events in the planning stage; After verification, the controlling shareholders did not buy or sell the company’s shares during the abnormal fluctuation of stock trading.
5. The reorganization of the company is being promoted in accordance with the enterprise bankruptcy law of the people’s Republic of China and other relevant provisions. 3、 Whether there is a description of the information that should be disclosed but not disclosed
The manager confirms that, except for the disclosed matters, there are no undisclosed matters or planning, negotiation, intention, agreement, etc. related to the matters that should be disclosed in accordance with the relevant provisions of the stock listing rules of Shenzhen Stock Exchange; The board of directors has not been informed that the company has undisclosed information that has a great impact on the trading price of the company’s shares and their derivatives that should be disclosed in accordance with the relevant provisions of the stock listing rules of Shenzhen Stock Exchange; The information disclosed by the company in the early stage does not need to be corrected or supplemented.
Hengkang Medical Group Co.Ltd(002219)
4、 Description of whether there is any violation of fair information disclosure
According to the company’s self-examination, the company has no violation of fair information disclosure.
5、 Risk tips
1. All the shares of the company held by the controlling shareholder Mr. que Wenbin have been frozen or waiting to be frozen by the court, and there is a possibility that some or all of them may be auctioned by the judiciary, resulting in great uncertainty for the controlling shareholder and actual controller of the company. Please make careful decisions and pay attention to investment risks.
2. Through self-examination, the company does not violate the fair disclosure of information.
3. The court has officially accepted the reorganization application of the company, and the company may be at risk of being ordered by the court to terminate the reorganization proceedings and declare bankruptcy due to the failure of reorganization. According to item (VI) of article 9.4.17 of the Listing Rules of Shenzhen Stock Exchange (revised in 2022) (hereinafter referred to as the “Listing Rules”), if the court decides that the company is bankrupt, the company’s shares will face the risk of delisting.
4. The manager reminds investors that the information disclosure media designated by the company are securities times, Securities Daily, China Securities News, Shanghai Securities News and cninfo (www.cn. Info. Com. CN), All information of the company is subject to the information disclosed in the above designated media. Please pay attention to the relevant announcements and pay attention to the investment risks.
It is hereby announced.
Hengkang Medical Group Co.Ltd(002219) administrator
February 8, 2002
